BioHealth News Archive
Mitochondria Shown to Regulate Brain’s CA2 Subregion, Highlighting a Potential Target for Neuro Disorders
A team of researchers has published evidence showing in mice that mitochondria-associated pathways in cell bodies and dendrites within the CA2 subregion of the…
Read More
Watch: How startups become unicorns, explained – STAT
Thanks to a yearslong boom in the world of venture capital, keeping tabs on biotech means constantly reading that some so-called startup is suddenly…
Read More
VC Money Is Flowing Into Biotechs
Venture capitalists are pouring cash into U.S. biotechs at a rate set to replicate 2018’s record deal count, according to PitchBook and the National…
Read More
Xconomy: Pharma, Biotech VC Investments Continue Shift to Early Stage Deals
The number of investments that venture capitalists will make this year in pharmaceutical and biotech companies is on pace to match last year’s record—and…
Read More
Room to Grow – LABORATORY/ OFFICE SPACE AVAILABLE
Alexandria Real Estate Equities, Inc (ARE) is committed to the Maryland I-270 Corridor market, and is a local partner and advocate for the biotech…
Read More
Diversity in Innovation QuickFire Challenge – Challenge | JLABS
Our vision at Johnson & Johnson is for every person to use their unique experiences and backgrounds together – to spark solutions that create…
Read More
Thank you BioHealth Innovation, Inc.
Thank you BioHealth Innovation, Inc. and AstraZeneca for another successful hashtag#BioHealth Capital Region BioBowl last night. The Children's National Hospital team had a blast.…
Read More
NEA Partner, Sara Nayeem, M.D., Joins Rich Bendis on BioTalk – Biohealth Innovation
New Enterprise Associates Partner, Sara Nayeem, M.D., Joins Host Rich Bendis to Discuss Her Career, Venture Capital, and BioPharma Sara Nayeem, M.D., is a…
Read More
Adaptive Phage Therapeutics Completes $7M Financing Round with Several Strategic Investors · BioBuzz
GAITHERSBURG, Md.–(BUSINESS WIRE)–Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR)…
Read More
Happening at the #BioInnovationConference
Happening now at the #BioInnovationConference, Henry Ahn of National Science Foundation (NSF), Joseph Naft of #MIPS, Judy Costello of BioHealth Innovation, Inc. , Paul…
Read More
Johns Hopkins researcher Gregg Semenza wins 2019 Nobel Prize in Physiology or Medicine | Hub
Gregg L. Semenza, whose discoveries on how cells respond to low oxygen levels have the potential to result in treatments for a variety of…
Read More
Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell Medicines Nasdaq:EDIT
CAMBRIDGE, Mass. and GAITHERSBURG, Md., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and MaxCyte, Inc.,…
Read More
Nobel Prize in Medicine Awarded to 3 for Work on Cells and Oxygen – The New York Times
The prize was awarded to William G. Kaelin Jr., Peter J. Ratcliffe and Gregg L. Semenza for their work in discovering how cells sense…
Read More
Why Baltimore rose to the ‘top of the list’ when this biotech team needed a new HQ – Technical.ly Baltimore
Research and startups are each important ingredients as the University of Maryland, Baltimore works to build a biotech community. In the case of recent…
Read More
MIMETAS and Hubrecht Organoid Technology to develop and market Organoids-on-a-Chip | Mimetas
Leiden, Utrecht October 2019 MIMETAS and Hubrecht Organoid Technology (HUB) announce that they entered into a strategic collaboration to market organoid models on a…
Read More